IL72381A - Pharmaceutical composition based on valproic acid - Google Patents

Pharmaceutical composition based on valproic acid

Info

Publication number
IL72381A
IL72381A IL72381A IL7238184A IL72381A IL 72381 A IL72381 A IL 72381A IL 72381 A IL72381 A IL 72381A IL 7238184 A IL7238184 A IL 7238184A IL 72381 A IL72381 A IL 72381A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
composition based
valproic acid
valproic
acid
Prior art date
Application number
IL72381A
Other versions
IL72381A0 (en
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8312376A external-priority patent/FR2549374B1/en
Priority claimed from FR8312375A external-priority patent/FR2549370B1/en
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL72381A0 publication Critical patent/IL72381A0/en
Publication of IL72381A publication Critical patent/IL72381A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL72381A 1983-07-20 1984-07-11 Pharmaceutical composition based on valproic acid IL72381A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8312376A FR2549374B1 (en) 1983-07-20 1983-07-20 MEDICINAL COMPOSITIONS BASED ON VALPROIC ACID FAVORABLY MODIFYING THEIR KINETICS AND THEIR GALENIC MANUFACTURING METHOD
FR8312375A FR2549370B1 (en) 1983-07-20 1983-07-20 NOVEL PHARMACEUTICAL COMPOSITION BASED ON VALPROIC ACID AND MANUFACTURING METHOD THEREOF

Publications (2)

Publication Number Publication Date
IL72381A0 IL72381A0 (en) 1984-11-30
IL72381A true IL72381A (en) 1988-03-31

Family

ID=26223536

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72381A IL72381A (en) 1983-07-20 1984-07-11 Pharmaceutical composition based on valproic acid

Country Status (13)

Country Link
US (1) US5017613A (en)
EP (1) EP0133110B1 (en)
JP (1) JPH0696524B2 (en)
KR (1) KR850000975A (en)
AU (1) AU563383B2 (en)
CA (1) CA1220718A (en)
DE (1) DE3469342D1 (en)
DK (1) DK161185C (en)
GR (1) GR79979B (en)
IL (1) IL72381A (en)
NZ (1) NZ208950A (en)
PH (1) PH21506A (en)
SG (1) SG52088G (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4913906B1 (en) * 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
JPH0667828B2 (en) * 1985-10-09 1994-08-31 日研化学株式会社 Sustained valproate granule formulation
SE8505569D0 (en) * 1985-11-25 1985-11-25 Aco Laekemedel Ab ENTERAL PREPARATION
IT1213508B (en) * 1986-10-22 1989-12-20 Foscama Biomed Chim Farma BUFLOMEDIL HYDROCHLORIDE-BASED PHARMACEUTICAL PREPARATION, UNDER CONTROLLED RELEASE COMPRESSED FORMATS AND RELATED PREPARATION PROCEDURE.
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
FR2643556B1 (en) * 1989-02-27 1993-03-05 Sanofi Sa PHARMACEUTICAL COMPOSITION WITH SUSTAINED RELEASE OF VALPROIC ACID
PT571973E (en) * 1992-05-29 2000-05-31 Nikken Chemicals Co Ltd DELAYED LIBERTACAO SODIUM VALPROATE TABLETS
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
NZ270438A (en) * 1995-02-02 1996-03-26 Bernard Charles Sherman Solid (granular) mixture of valproic acid (di-n-propyl acetic acid) and its sodium salt; pharmaceutical compositions
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
JPH09323926A (en) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd Sustained release tablet of sodium valproate
FR2754177B1 (en) * 1996-10-07 1999-08-06 Sanofi Sa PHARMACEUTICAL MICROSPHERES OF VALPROIC ACID FOR ORAL ADMINISTRATION
DE19840152A1 (en) * 1998-09-03 2000-03-09 Dresden Arzneimittel Pharmaceutical compositions containing calcium valproate with a delayed release of active substance, process for their preparation and their use
AR020343A1 (en) * 1998-11-24 2002-05-08 Steigerwald Arzlneimittelwerk METHOD TO PRODUCE PHARMACES CONTAINING EXTRACTS OF PLANTS IN A SOLID FORM OF APPLICATION.
US6511678B2 (en) 1998-12-18 2003-01-28 Abbott Laboratories Controlled release formulation of divalproex sodium
US6528090B2 (en) 1998-12-18 2003-03-04 Abbott Laboratories Controlled release formulation of divalproex sodium
US20020031549A1 (en) * 1998-12-18 2002-03-14 Yihong Qiu Controlled release formulation of divalproex sodium
US6419953B1 (en) * 1998-12-18 2002-07-16 Abbott Laboratories Controlled release formulation of divalproex sodium
US6713086B2 (en) 1998-12-18 2004-03-30 Abbott Laboratories Controlled release formulation of divalproex sodium
US6150410A (en) * 1999-02-04 2000-11-21 Abbott Laboratories pH independent extended release pharmaceutical formulation
WO2000045793A1 (en) * 1999-02-04 2000-08-10 Abbott Laboratories Ph independent extended release pharmaceutical formulation
US6753349B1 (en) 1999-11-02 2004-06-22 Cilag Ag Method of preparing valproinic acid compounds
US20020132010A1 (en) * 2000-12-22 2002-09-19 Yihong Qui Divalproex sodium dosage forms and a process for their production
US20020143058A1 (en) 2001-01-24 2002-10-03 Taro Pharmaceutical Inductries Ltd. Process for preparing non-hygroscopic sodium valproate composition
US20040105886A1 (en) * 2001-02-16 2004-06-03 Chih-Ming Chen Divalproex sodium tablets
US6610326B2 (en) 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
BR0311642A (en) * 2002-06-07 2005-03-01 Ranbaxy Lab Ltd Increased Release Sodium Divalproex Formulation
KR20050083971A (en) 2002-11-22 2005-08-26 더 존스 홉킨스 유니버시티 Target for therapy of cognitive impairment
US20050276848A1 (en) * 2004-06-15 2005-12-15 Nilobon Podhipleux Sustained release neutralized divalproex sodium
US20050276849A1 (en) * 2004-06-15 2005-12-15 Nilobon Podhipleux Sustained release dosage forms
US7713550B2 (en) * 2004-06-15 2010-05-11 Andrx Corporation Controlled release sodium valproate formulation
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
AU2005320547B2 (en) * 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
HK1081802A2 (en) * 2005-09-09 2006-05-19 Jacky Lam Chi Sum Intelligent crossroad
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
CN102227217A (en) 2008-10-16 2011-10-26 约翰斯.霍普金斯大学 Methods and compositions for improving cognitive function
EP2533645B1 (en) * 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
KR101733189B1 (en) 2010-10-06 2017-05-08 (주)아모레퍼시픽 Composition for promotion of growing nail or toenail
GB201020133D0 (en) * 2010-11-26 2011-01-12 Royal Holloway & Bedford New College Therapeutic use of compounds
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins Methods and compositions for treating schizophrenia
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins Methods and compositions for improving cognitive function
DK2968220T3 (en) 2013-03-15 2021-06-14 Agenebio Inc PROCEDURES AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
JP6456377B2 (en) * 2014-06-10 2019-01-23 ライオン株式会社 Tablets containing sake yeast
BR112017025031B1 (en) 2015-05-22 2023-03-21 Agenebio, Inc LEVETIRACETAM EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS
CN108578678A (en) * 2018-03-13 2018-09-28 孟斯琴 A kind of antiepileptic compositions and preparation method thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB760114A (en) * 1953-06-19 1956-10-31 Chimie Atomistique Improvements in and relating to compositions for lowering the cholesterol level in the blood serum
FR2442M (en) * 1962-10-17 1964-04-06 Henry Eugene Dipropylacetic acid and its derivatives as new central nervous system depressants.
FR2077918B1 (en) * 1970-02-24 1973-04-06 Berthier Laboratoires
NL7115745A (en) * 1971-11-16 1973-05-18 Dipropylacetic acid derivs - as anticonvulsants, tranquillizers muscle relaxants, antipyretics and diuretics
FR2383907A1 (en) * 1977-03-15 1978-10-13 Labaz PROCESS FOR PREPARING DERIVATIVES OF ACETIC ACID AND DERIVATIVES OBTAINED BY THIS PROCESS
IL59407A (en) * 1979-03-06 1983-12-30 Sanofi Sa Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them
US4654370A (en) * 1979-03-12 1987-03-31 Abbott Laboratories Glyceryl valproates
IT1121282B (en) * 1979-06-08 1986-04-02 Medea Res Srl COMPOUND WITH ANTIEPILEPTIC AND ANTICONVULSIVE ACTIVITY, PROCESS FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
AU538751B2 (en) * 1979-08-20 1984-08-23 Abbott Laboratories Complex valproate salts
US4301176A (en) * 1980-08-18 1981-11-17 Warner-Lambert Company Method of administering calcium valproate
LU83729A1 (en) * 1981-11-04 1983-09-01 Galephar VALPROIC ACID SALTS, THEIR PREPARATION AND THEIR USE
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2547499A1 (en) * 1983-06-15 1984-12-21 Opochimiotherapie Lab Medicaments containing calcium dipropylacetate
FR2549371B1 (en) * 1983-07-20 1985-09-13 Sanofi Sa NOVEL PHARMACEUTICAL COMPOSITION CONTAINING VALPROIC ACID OR ONE OF ITS SALTS
US4558070A (en) * 1983-10-26 1985-12-10 Abbott Laboratories Acid salts of valproic acid
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4913906B1 (en) * 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
DE3709230A1 (en) * 1987-03-20 1988-10-06 Desitin Arzneimittel Gmbh NEW VALPROINIC ACID CALCIUM

Also Published As

Publication number Publication date
AU3075584A (en) 1985-01-24
DE3469342D1 (en) 1988-03-24
EP0133110A1 (en) 1985-02-13
US5017613A (en) 1991-05-21
GR79979B (en) 1984-10-31
KR850000975A (en) 1985-03-14
NZ208950A (en) 1987-09-30
JPS6041610A (en) 1985-03-05
DK351984A (en) 1985-01-21
SG52088G (en) 1989-01-27
DK351984D0 (en) 1984-07-18
PH21506A (en) 1987-11-10
DK161185C (en) 1991-11-25
CA1220718A (en) 1987-04-21
DK161185B (en) 1991-06-10
JPH0696524B2 (en) 1994-11-30
AU563383B2 (en) 1987-07-09
EP0133110B1 (en) 1988-02-17
IL72381A0 (en) 1984-11-30

Similar Documents

Publication Publication Date Title
IL72381A0 (en) Pharmaceutical composition based on valproic acid
JPS57176941A (en) N-substituted-amide-amino acid
EP0138029A3 (en) Pharmaceutical composition
GB8431527D0 (en) Fatty acid composition
GB2154586B (en) Phenoxyalkanoic acid esters
DE3365829D1 (en) Pharmaceutical composition containing an aliphatic aminosulphonic acid
JPS57165355A (en) Amide-amino acid
GB8417154D0 (en) Pharmaceutical composition
AU564922B2 (en) Alpha ketoisocaproic acid solution
GB2123817B (en) 4-hydroxy-3-quinoline-carboxylic acid derivatives
GB2103232B (en) Arylazo-aminonaphtholsulfonic acid
DE3371070D1 (en) 4-amino-tetrahydro-2-naphthoic acid derivatives
GB8301926D0 (en) N-methanesulfonic acid derivatives
GB2110930B (en) Pharmaceutical compositions containing propionhydroxamic acid
GB8407735D0 (en) Pharmaceutical composition
GB8318345D0 (en) Isocarbostyryl-3-carboxylic acid derivatives
GB2110536B (en) Pharmaceutical compositions containing pantetheine-s-sulphonic acid
GB2124214B (en) Apovincaminic acid derivatives
GB8320494D0 (en) Aminolactonecarboxylic acid
AU564421B2 (en) Lipoteictioic acid antitomor agent
GB2121408B (en) Tetrazolylalkanohydroxamic acid derivatives
GB8308414D0 (en) Pharmaceutical composition
GR80030B (en) Pharmaceutical compositions based on quinine
IE832972L (en) Cyclopropanecarboxylic acid derivatives
DE3366930D1 (en) New phenylthionophosphonic acid esters

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
EXP Patent expired